France Viscosupplementation Market Report 2022 to 2030

France Viscosupplementation Market Analysis

$ 3999

France Viscosupplementation Market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. Viscosupplementation market is growing globally due to the increasing prevalence of osteoarthritis, growing aging population, and rising awareness about minimally invasive treatment options, increasing awareness and acceptance, technological advancements in viscosupplementation treatments, rise in the healthcare sector spending and infrastructure. Anika Therapeutics, Inc., SEIKAGAKU CORPORATION, Bioventus, Fidia Farmaceutici S.P.A, Ferring B.V, sanofi-aventis U.S. LLC, Zimmer Biomet, OrthogenRx, Inc. (a subsidiary of AVNS), APTISSEN, Johnson & Johnson Services, Inc., LG Chem., Viatris Inc., IBSA Institut Biochimique SA, Ortobrand International, TRB CHEMEDICA SA, Teva Pharmaceutical Industries Ltd., Lifecore (a subsidiary of Landec Corporation), VIRCHOW are the key global market players of viscosupplementation market.

ID: IN10FRPH419 CATEGORY: Pharmaceuticals GEOGRAPHY: France AUTHOR: Riddhi Solanki

Buy Now

France Viscosupplementation Market Analysis Summary

France Viscosupplementation Market is valued at around $67.7 Mn in 2022 and is projected to reach $135.9 Mn by 2030, exhibiting a CAGR of 9.1% during the forecast period 2023-2030.

The medical treatment known as viscosupplementation is used to treat osteoarthritis, a degenerative joint disease. To promote lubrication, lessen pain, and enhance joint function, hyaluronic acid (HA) is directly injected into the troubled joint. The major goal of viscosupplementation is to replenish the synovial fluid in the joint's natural lubricating abilities, which are lost in people with osteoarthritis. Natural lubricant and shock-absorber hyaluronic acid, which is present in the body, helps joints move more smoothly and with less friction. During the viscosupplementation procedure, a healthcare professional injects hyaluronic acid into the joint space using a sterile needle. Viscosupplementation seeks to increase joint mobility and temporarily relieve discomfort. Patients who have not responded effectively to more conventional forms of treatment, such as oral painkillers, physical therapy, and lifestyle changes, are frequently advised to try it. Brands like Synvisc, Orthovisc, Supartz, Euflexxa, and Hyalgan are a few that are frequently utilized.

Viscosupplementation can help with symptoms of osteoarthritis, but it is crucial to remember that it is not a cure-all and that its effects only last a short time. Anika Therapeutics, Inc., SEIKAGAKU CORPORATION, Bioventus, Fidia Farmaceutici S.P.A, Ferring B.V, Sanofi-aventis U.S. LLC, Zimmer Biomet, OrthogenRx, Inc. (a subsidiary of AVNS), APTISSEN, Johnson & Johnson Services, Inc., LG Chem., Viatris Inc., IBSA Institut Biochimique SA, Ortobrand International, TRB CHEMEDICA SA, Teva Pharmaceutical Industries Ltd., Lifecore (a subsidiary of Landec Corporation), VIRCHOW are the key global market players of viscosupplementation market.

Market Dynamics

Market Growth Drivers

The increasing prevalence of osteoarthritis, growing aging population, rising awareness about minimally invasive treatment options, increasing awareness and acceptance, technological advancements in viscosupplementation treatments, and rise in the healthcare sector spending and infrastructure act as market growth drivers.

Market Restraints

High cost of viscosupplementation procedures, limited insurance coverage, efficacy and varying treatment outcomes in different individuals, competition from alternative treatments like oral medications, physical therapy, weight management, and regulatory approval challenges act as market growth restraints.

Competitive Landscape

Key Players

?Anika Therapeutics, Inc.
SEIKAGAKU CORPORATION
Bioventus
Fidia Farmaceutici S.P.A
Ferring B.V
sanofi-aventis U.S. LLC
Zimmer Biomet
OrthogenRx, Inc. (a subsidiary of AVNS)
APTISSEN
Johnson & Johnson Services, Inc.
LG Chem.
Viatris Inc.
IBSA Institut Biochimique SA
Ortobrand International
TRB CHEMEDICA SA
Teva Pharmaceutical Industries Ltd.
Lifecore (a subsidiary of Landec Corporation)
VIRCHOW

1. Executive Summary
1.1 Disease Overview
1.2 Global Scenario
1.3 Country Overview
1.4 Healthcare Scenario in Country
1.5 Patient Journey
1.6 Health Insurance Coverage in Country
1.7 Active Pharmaceutical Ingredient (API)
1.8 Recent Developments in the Country

2. Market Size and Forecasting
2.1 Epidemiology of Disease
2.2 Market Size (With Excel & Methodology)
2.3 Market Segmentation (Check all Segments in Segmentation Section)

3. Market Dynamics
3.1 Market Drivers
3.2 Market Restraints

4. Competitive Landscape
4.1 Major Market Share

4.2 Key Company Profile (Check all Companies in the Summary Section)

4.2.1 Company
4.2.1.1 Overview
4.2.1.2 Product Applications and Services
4.2.1.3 Recent Developments
4.2.1.4 Partnerships Ecosystem
4.2.1.5 Financials (Based on Availability)

5. Reimbursement Scenario
5.1 Reimbursement Regulation
5.2 Reimbursement Process for Diagnosis
5.3 Reimbursement Process for Treatment

6. Methodology and Scope

Market Segmentations For France Viscosupplementation Market

By Source

Animal Origin
Non-Animal Origin

By Age Group

Geriatric
Adults

By Injection

Single Injection
Three Injections
Five Injections

By Molecular Weight

Intermediate Molecular Weight
Low Molecular Weight
High Molecular Weight

By End User

Hospital
Orthopaedic Clinics
Ambulatory Care Centers
Others

By Distribution Channel

Direct Tender
Retail Sales

Methodology for Database Creation

Our database offers a comprehensive list of healthcare centers, meticulously curated to provide detailed information on a wide range of specialties and services. It includes top-tier hospitals, clinics, and diagnostic facilities across 30 countries and 24 specialties, ensuring users can find the healthcare services they need.

Additionally, we provide a comprehensive list of Key Opinion Leaders (KOLs) based on your requirements. Our curated list captures various crucial aspects of the KOLs, offering more than just general information. Whether you're looking to boost brand awareness, drive engagement, or launch a new product, our extensive list of KOLs ensures you have the right experts by your side. Covering 30 countries and 36 specialties, our database guarantees access to the best KOLs in the healthcare industry, supporting strategic decisions and enhancing your initiatives.

How Do We Get It?

Our database is created and maintained through a combination of secondary and primary research methodologies.

1. Secondary Research

With many years of experience in the healthcare field, we have our own rich proprietary data from various past projects. This historical data serves as the foundation for our database. Our continuous process of gathering data involves:

Analyzing historical proprietary data collected from multiple projects.
Regularly updating our existing data sets with new findings and trends.
Ensuring data consistency and accuracy through rigorous validation processes.

With extensive experience in the field, we have developed a proprietary GenAI-based technology that is uniquely tailored to our organization. This advanced technology enables us to scan a wide array of relevant information sources across the internet. Our data-gathering process includes:

Searching through academic conferences, published research, citations, and social media platforms
Collecting and compiling diverse data to build a comprehensive and detailed database
Continuously updating our database with new information to ensure its relevance and accuracy

2. Primary Research

To complement and validate our secondary data, we engage in primary research through local tie-ups and partnerships. This process involves:

Collaborating with local healthcare providers, hospitals, and clinics to gather real-time data.
Conducting surveys, interviews, and field studies to collect fresh data directly from the source.
Continuously refreshing our database to ensure that the information remains current and reliable.
Validating secondary data through cross-referencing with primary data to ensure accuracy and relevance.

Combining Secondary and Primary Research

By integrating both secondary and primary research methodologies, we ensure that our database is comprehensive, accurate, and up-to-date. The combined process involves:

Merging historical data from secondary research with real-time data from primary research.
Conducting thorough data validation and cleansing to remove inconsistencies and errors.
Organizing data into a structured format that is easily accessible and usable for various applications.
Continuously monitoring and updating the database to reflect the latest developments and trends in the healthcare field.

Through this meticulous process, we create a final database tailored to each region and domain within the healthcare industry. This approach ensures that our clients receive reliable and relevant data, empowering them to make informed decisions and drive innovation in their respective fields.